Literature DB >> 13694490

The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.

Z A COHN, J G HIRSCH.   

Abstract

A method has been described for isolation of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. Homogeneous suspensions of leucocytes were disrupted by lysis in 0.34 M sucrose. This procedure liberated the cytoplasmic contents of the cell and dissolved a considerable proportion of the nuclei. Following disruption, the sucrose lysate was separated into three fractions by differential centrifugation, i.e. 400 g or nuclear pellet, 8,200 g or granule pellet and the postgranule supernate. Microscopic examination revealed that the 8,200 g pellet was composed of intact granules as well as occasional mitochondria. The other two fractions were morphologically heterogeneous. Studies with isolated granules demonstrated their lysis by a variety of weak acids and surface-active agents. When buffered solutions were employed between the ranges of pH 2.0 and 9.0, granule lysis began at pH 5.5 and was complete at pH 4.0. Chemical analysis disclosed that the granule pellet contained protein and phospholipid with only traces of nucleic acids. Approximately 70 to 80 per cent of the total cellular antimicrobial agent phagocytin was present in the granule fraction. This material was liberated from the granules by acid (pH 5.0 or lower). Studies on selected enzymes showed that acid phosphatase, alkaline phosphatase, nucleotidase, ribonuclease, deoxyribonuclease, and beta glucuronidase were predominantly localized in the granule fraction. Approximately 50 per cent of total cellular lysozyme and cathepsin were also present in the 8,200 g pellet. Disruption of the granules was associated with the release of the majority of granule protein and enzymes in a non-sedimentable form. The properties and composition of rabbit polymorphonuclear leucocyte granules seem to be analogous to those of liver lysosomes.

Entities:  

Keywords:  LEUKOCYTES

Mesh:

Substances:

Year:  1960        PMID: 13694490      PMCID: PMC2137322          DOI: 10.1084/jem.112.6.983

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  [Leukocyte metabolism in phagocytosis].

Authors:  H BECKER; G MUNDER; H FISCHER
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1958

2.  Intracellular distribution of enzymes. X. Desoxyribonuclease and ribonuclease.

Authors:  W C SCHNEIDER; G H HOGEBOOM
Journal:  J Biol Chem       Date:  1952-09       Impact factor: 5.157

3.  Variations in nucleotidase activity of leukocytes; studies with leukemia patients.

Authors:  M E SWENDSEID; P D WRIGHT; F H BETHELL
Journal:  J Lab Clin Med       Date:  1952-10

4.  The beta glucuronidase content of human leukocytes in health and in disease.

Authors:  J H FOLLETTE; W N VALENTINE; J S LAWRENCE
Journal:  J Lab Clin Med       Date:  1952-12

5.  Biochemical studies on leucocytes. I. Phosphatase activity in health, leucocytosis, and myelocytic leucemia.

Authors:  W N VALENTINE; W S BECK
Journal:  J Lab Clin Med       Date:  1951-07

6.  The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme.

Authors:  D SHUGAR
Journal:  Biochim Biophys Acta       Date:  1952-03

7.  Surface-active substances and the liberation of enzymes from rabbit polymorphonuclear leucocytes.

Authors:  R J ROSSITER
Journal:  J Physiol       Date:  1949-12-15       Impact factor: 5.182

8.  Bactericidal action of histone.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

9.  Further studies on preparation and properties of phagocytin.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  215 in total

1.  Effect of various lysosomes and endotoxin on vascular permeability in frogs and mice.

Authors:  G Csákó; A Reichel; H Csernyánszky; U Reichel
Journal:  Pflugers Arch       Date:  1975       Impact factor: 3.657

2.  Effect of pneumococci on blood clotting, platelets, and polymorphonuclear leukocytes.

Authors:  J C Guckian
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

3.  PHAGOCYTOSIS OF BACTERIA BY HETEROPHIL LEUKOCYTES: ACID AND ALKALINE PHOSPHATASE CYTOCHEMISTRY.

Authors:  R G HORN; S S SPICER; B K WETZEL
Journal:  Am J Pathol       Date:  1964-08       Impact factor: 4.307

4.  DIFFERENTIAL RELEASE OF LYSOZYME AND ACID PHOSPHATASE FROM SUB-CELLULAR GRANULES OF NORMAL RABBIT ALVEOLAR MACROPHAGES.

Authors:  E S LEAKE; Q N MYRVIK
Journal:  Br J Exp Pathol       Date:  1964-08

Review 5.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

6.  ELECTRON MICROSCOPICAL OBSERVATIONS ON THE PERITONEAL MACROPHAGES OF NORMAL MICE AND MICE IMMUNISED WITH LISTERIA MONOCYTOGENES. I. STRUCTURE OF NORMAL MACROPHAGES AND THE EARLY CYTOPLASMIC RESPONSE TO THE PRESENCE OF INGESTED BACTERIA.

Authors:  R J NORTH; G B MACKANESS
Journal:  Br J Exp Pathol       Date:  1963-12

7.  INTRACYTOPLASMIC VIRUS CRYSTAL FORMATION AND OTHER ALLTERATIONS IN POLYMORPHONUCLEAR LEUKOCYTES IN MOUSE POLIOENCEPHALITIS (MM STRAIN).

Authors:  E NELSON; H HAGER; E KOVACS
Journal:  Am J Pathol       Date:  1964-01       Impact factor: 4.307

8.  CATIONIC PROTEINS AND ANTIBACTERIAL PROPERTIES OF INFECTED TISSUES AND LEUKOCYTES.

Authors:  J K SPITZNAGEL; H Y CHI
Journal:  Am J Pathol       Date:  1963-10       Impact factor: 4.307

9.  STUDIES WITH AN ANTIBODY TO RAT LYSOZYME.

Authors:  A A GLYNN; R PARKMAN
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

10.  Morphological changes associated with the extrusion of protein induced in the polymorphonuclear leucocyte by staphylococcal leucocidin.

Authors:  A M WOODIN; J E FRENCH; V T MARCHESI
Journal:  Biochem J       Date:  1963-06       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.